A retrospective review of pain control by a two‐step irradiance schedule during topical ALA‐photodynamic therapy of non‐melanoma skin cancer
- 6 February 2013
- journal article
- review article
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 45 (2) , 89-94
Abstract
Background and Objective: Photodynamic therapy (PDT) with topical δ‐aminolevulinic acid (ALA) of non‐melanoma skin cancers is often associated with treatment‐limiting pain. A previous study on basal cell carcinomas (BCCs) at Roswell Park Cancer Institute evaluated a two‐step irradiance scheme as a means of minimizing pain, preserving outcomes, and limiting treatment time. We used an initial low irradiance until 90% of the protoporphyrin IX was photobleached, followed by a high irradiance interval until the prescribed fluence was delivered. Success of this pilot investigation motivated integration of the protocol into routine practice. Here, we present a retrospective review of recent clinical experience in a broad patient population.Study Design/Materials and Methods: This was a retrospective review of an existing dermatology database. Fourteen caucasion patients—nine men and five women, ages 18–80, with a total of 51 superficial and 73 nodular BCCs, and three Bowen's disease lesions—were included. ALA was applied to each lesion for approximately 4 hours. Lesions received an initial irradiance of 30–50 mW/cm2 for 20 J/cm2, followed by 150 mW/cm2 for a total fluence of 200–300 J/cm2. Pain was assessed using a visual analog scale (VAS). Clinical outcome was determined at 6–12 months.Results: Median VAS scores were 1.0 for both irradiances. Five of 127 lesions required pain control with 1% xylocaine. Pain was strongly influenced by lesion location but not by lesion type, number, or size. Complete responses were achieved in 84.1% of BCCs, which compares favorably with reported results for single ALA‐PDT treatments. Two of three Bowen's disease lesions showed a complete response. Complete responses for nodular BCCs were 37%, which are also within the range of reported outcomes.Conclusions: A two‐step irradiance protocol in ALA‐PDT effectively minimizes pain, maintains excellent clinical outcomes in superficial lesions, and adds minimal treatment time. Lasers Surg. Med. 45: 89–94, 2013.Keywords
This publication has 25 references indexed in Scilit:
- A Quantitative Comparison of 5‐Aminolaevulinic Acid‐ and Methyl Aminolevulinate‐Induced Fluorescence, Photobleaching and Pain During Photodynamic TherapyPhotochemistry and Photobiology, 2010
- Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodesBritish Journal of Dermatology, 2010
- Pain associated with aminolevulinic acid-photodynamic therapy of skin diseaseJournal of the American Academy of Dermatology, 2009
- Topical photodynamic therapy with porphyrin precursors—assessment of treatment-associated pain in a retrospective studyPhotochemical & Photobiological Sciences, 2009
- Guidelines for topical photodynamic therapy: updateBritish Journal of Dermatology, 2008
- Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell CarcinomasClinical Cancer Research, 2008
- Light Delivery over Extended Time Periods Enhances the Effectiveness of Photodynamic TherapyClinical Cancer Research, 2008
- Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded studyBritish Journal of Dermatology, 2005
- Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapyClinical and Experimental Dermatology, 2004
- Oxygen Consumption and Diffusion Effects in Photodynamic TherapyRadiation Research, 1991